NDC properties for NDC 9 31722-666
NDC item 31722066631
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-31 |
| NDC Item | 31722066631 |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
NDC item 31722066632
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-32 |
| NDC Item | 31722066632 |
| packaging | 10 BLISTER PACK in 1 CARTON (31722-666-32) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
NDC item 31722066660
| NDC 9 | 31722-666 |
|---|---|
| NDC 10 | 31722-666-60 |
| NDC Item | 31722066660 |
| packaging | 60 CAPSULE in 1 BOTTLE (31722-666-60) |
| ANDA | ANDA207961 |
| COLORTEXT | white(cream opaque cap and cream opaque body) |
| Color | C48325 __ |
| FDA SPL set id | 813537 |
| Imprint code | H;D16 |
| Labeler | Camber Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
NDC item 46708063506
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-06 |
| NDC Item | 46708063506 |
| packaging | 10 BLISTER PACK in 1 CARTON (46708-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
NDC item 46708063560
| NDC 9 | 46708-635 |
|---|---|
| NDC 10 | 46708-635-60 |
| NDC Item | 46708063560 |
| packaging | 60 CAPSULE in 1 BOTTLE (46708-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 803987 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
NDC item 60505434906
| NDC 9 | 60505-4349 |
|---|---|
| NDC 10 | 60505-4349-6 |
| NDC Item | 60505434906 |
| packaging | 60 CAPSULE in 1 BOTTLE (60505-4349-6) |
| ANDA | ANDA208070 |
| COLORTEXT | YELLOW |
| Color | C48330 __ |
| FDA SPL set id | 799185 |
| Imprint code | APO;D110 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-02-13 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
NDC item 62332063506
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-06 |
| NDC Item | 62332063506 |
| packaging | 10 BLISTER PACK in 1 CARTON (62332-635-06) / 6 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
NDC item 62332063560
| NDC 9 | 62332-635 |
|---|---|
| NDC 10 | 62332-635-60 |
| NDC Item | 62332063560 |
| packaging | 60 CAPSULE in 1 BOTTLE (62332-635-60) |
| ANDA | ANDA215233 |
| COLORTEXT | BLUE(Light blue opaque) |
| Color | C48333 __ |
| FDA SPL set id | 804091 |
| Imprint code | A;192 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-13 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
NDC item 72205020334
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-34 |
| NDC Item | 72205020334 |
| packaging | 6 BLISTER PACK in 1 CARTON (72205-203-34) / 10 CAPSULE in 1 BLISTER PACK |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |
NDC item 72205020360
| NDC 9 | 72205-203 |
|---|---|
| NDC 10 | 72205-203-60 |
| NDC Item | 72205020360 |
| packaging | 60 CAPSULE in 1 BOTTLE (72205-203-60) |
| ANDA | ANDA213879 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 820439 |
| Imprint code | MD;110 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-12 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 19 mm |